Build a Proactive Revenue Shield with rpm in health care Amid UnitedHealthcare’s RPM Coverage Pause

Remote patient monitoring (RPM) is a Medicare-covered service that lets clinicians track health data from a patient’s home using devices and apps. It’s designed to keep chronic conditions stable and reduce unnecessary visits. In Australia, the model is still evolving, but recent US insurer moves have ripple effects on local providers and patients.

2024 saw UnitedHealthcare delay a controversial policy that would have cut coverage for RPM devices, a decision reported by STAT on Dec 18, 2024. The pause shows how fragile reimbursement can be and why Australian clinicians need a solid footing in local rules.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Understanding RPM and Its Role in Australian Health Care

Key Takeaways

• RPM lets doctors monitor chronic disease from home.
• Medicare (MBS) covers specific RPM items since 2022.
• Accurate billing hinges on documentation and device certification.
• US insurer pull-backs highlight the need for local policy stability.
• Practices can earn up to $647,000 a year if they capture all RPM revenue.

Here's the thing: in my experience around the country, the biggest barrier to RPM uptake isn’t technology - it’s the paperwork. When I visited a regional GP clinic in Tamworth, the nurse told me they had three Bluetooth blood-pressure cuffs sitting idle because no one knew how to bill the service correctly.

First, let’s break down what the Medicare Benefits Schedule (MBS) actually pays for. Since the 2022 update, the following items are relevant:

• MBS 71013: Setup and education for a patient’s monitoring device (up to $33).
• MBS 71014: Review of transmitted data - up to 20 minutes (up to $55).
• MBS 71015: Ongoing management - per month, per patient (up to $80).

Each of those items requires a signed consent form, a device that meets the Therapeutic Goods Administration (TGA) standards, and a clear log of the data reviewed. Miss any of those, and the claim is rejected - a painful lesson I saw first-hand when a Sydney practice lost $2,400 in a month because a therapist forgot to attach the consent PDF.

Why RPM matters for chronic disease

According to the Australian Institute of Health and Welfare, more than 4.3 million Australians live with at least one chronic condition - diabetes, COPD, heart failure, you name it. Remote monitoring can:

1. Detect deterioration early: A 2023 AIHW analysis showed that patients who received weekly weight uploads for heart failure had a 15% lower readmission rate.
2. Cut travel time: Rural patients saved an average of 2.5 hours per month, freeing up time for work or family.
3. Improve medication adherence: Digital reminders linked to the device boost compliance by about 12%.
4. Support personalised care plans: Clinicians can adjust doses or lifestyle advice based on real-time trends.

But the upside only materialises when the service is billed correctly and the data is acted upon. That’s why I always stress a two-pronged approach: technology + process.

Step-by-step guide to claim Medicare RPM

1. Choose a TGA-approved device. Look for the "Australian Registered" mark - it signals the device meets safety standards.
2. Obtain written consent. The patient must sign a form that outlines data use, privacy, and the duration of monitoring.
3. Document the setup session. Record device serial number, training date, and the staff member who provided instruction - this supports MBS 71013.
4. Upload data securely. Use a Health Level-7 (HL7) compatible platform that integrates with your practice management software.
5. Review the data within 48 hours. Note any alerts, trends, or interventions - this backs MBS 71014.
6. Submit the monthly management claim. Attach the consent form, device log, and a brief narrative of the clinical decision made.
7. Audit regularly. Every quarter, run a report to confirm that each claim has the required attachments; otherwise, expect a rejection.

In my nine years of health reporting, I’ve seen clinics that treat the audit as a chore and those that embed it into their workflow. The latter not only avoid denied claims but also build a culture of data-driven care.

Comparing RPM to traditional in-person follow-up

The numbers speak for themselves - RPM can halve costs while improving outcomes. That’s why the ACCC has been keeping an eye on market concentration among device manufacturers, ensuring no single player can dictate prices.

What the UnitedHealthcare saga teaches us

On Dec 18, 2024, STAT reported that UnitedHealthcare halted a plan to roll back RPM coverage after backlash from clinicians who argued the move ignored robust evidence of benefit. Modern Healthcare later confirmed the insurer’s pause, noting that the decision was influenced by a pending federal review of Medicare policy. Healthcare Finance News added that the delay could preserve up to $1 billion in US patient-level savings annually.

Why should Aussies care? The episode underscores two points:

• Policy can shift overnight. If a major US payer can reverse a decision in weeks, we can’t rely on foreign insurers to set a stable precedent for our own Medicare framework.
• Evidence matters. UnitedHealthcare cited “no evidence” for RPM, yet multiple peer-reviewed studies - including a 2023 AIHW meta-analysis - demonstrate reduced hospitalisations. That gap between perception and data is what we must bridge locally.

Back home, the Therapeutic Goods Administration and the Department of Health have been more cautious, rolling out a national “Digital Health Futures” strategy in 2023 that earmarks $300 million for RPM pilots in Aboriginal health services. It’s a fair-dinkum attempt to test the model before full national rollout.

Practical tips for Australian providers

1. Start small. Pilot RPM with one chronic condition - e.g., type-2 diabetes - before expanding.
2. Partner with a reputable vendor. Choose companies that provide device certification, integration support, and a clear privacy policy.
3. Train the whole team. Receptionists need to know how to hand out devices; clinicians must understand data thresholds.
4. Build a data-review protocol. Decide who looks at the data each day and what alerts trigger a call.
5. Document every interaction. Use a dedicated field in your EMR to capture RPM notes - this simplifies audits.
6. Leverage Medicare rebates. Combine RPM with Chronic Disease Management plans (MBS 721) for bundled payments.
7. Monitor your revenue. The AIHW notes that most primary-care practices miss up to $647,000 a year in Medicare revenue because they don’t claim every eligible service.
8. Stay updated on policy. Subscribe to the Department of Health’s newsletter - policy changes roll out quarterly.
9. Engage patients early. Explain how RPM will reduce their trips to the clinic - a simple 5-minute conversation can boost uptake.
10. Evaluate outcomes. Every six months, compare readmission rates, medication adherence, and patient satisfaction before and after RPM.

I've seen this play out in a Melbourne cardiac rehab program that added RPM for weight and blood pressure. Within a year, they cut their 30-day readmission rate from 9% to 5%, saving the health service over $200,000.

Future outlook - where RPM is heading in Australia

Looking ahead, three trends will shape RPM adoption:

• AI-enhanced analytics. Platforms are integrating machine-learning algorithms that flag subtle changes before clinicians notice.
• Bundled digital health contracts. Some private insurers are negotiating “whole-of-system” deals that include RPM, telehealth, and e-prescribing.
• Greater patient co-design. Trials with Aboriginal communities are putting patients at the centre of device selection, improving cultural safety.

Ultimately, the goal is simple: keep Australians healthier at home and keep the health system financially sustainable. If we nail the billing, the technology and the policy will follow.

Q: What exactly does Medicare cover under RPM?

A: Medicare (MBS) funds three items - device setup (71013), data review (71014) and ongoing monthly management (71015). Each claim requires a TGA-approved device, written consent and documented clinical decisions.

Q: How can a practice avoid claim rejections?

A: Keep a checklist - device certification, consent form, session notes, data-review timestamps. Run quarterly audits to confirm every claim has the required attachments before submission.

Q: Are there any risks if a private insurer pulls back RPM coverage?

A: Yes. The UnitedHealthcare episode (STAT, 2024) showed that sudden policy changes can strip away revenue streams. In Australia, reliance on MBS items mitigates that risk, but private contracts should include renewal clauses.

Q: What devices are considered TGA-approved for RPM?

A: Devices bearing the “Australian Registered” mark - such as Bluetooth blood-pressure cuffs, glucometers, pulse-oximeters and weight scales - meet TGA requirements. Always verify the registration number on the device label.

Q: How much can a practice realistically earn from RPM?

A: AIHW research suggests many practices miss up to $647,000 a year. By claiming all three MBS items for each eligible patient, a medium-sized clinic could add $120-$150 k annually, depending on patient volume.